• Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Hold" from Analysts

    来源: Buzz FX / 23 9月 2024 05:01:10   America/New_York


    Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Hold" from Analysts Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Revance Therapeutics, Inc. ( NASDAQ:RVNC - Get Free Report ) has earned an ave
    Read more...
分享